Image4_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.TIF by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Image9_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.TIF by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Image11_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.TIF by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Image8_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.TIF by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Presentation1_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.pdf by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Image2_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.TIF by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Image7_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.TIF by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Image6_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.TIF by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Image1_Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.TIF by Leonardo Y. Tanaka (18306715)

“…Our search identified that miR-204-5p and miR-211-5p (miR-204/211), two broadly conserved miRNAs, share PDIA1 as a potential target. …”

Restoration of FcMBL-mediated capture of <i>S</i>. <i>aureus</i> from infected articular fluids and synovial tissues. by A. Bicart-See (2825180)

“…Addition of an enzymatic cocktail of proteases and hyaluronidase (Enzymes) to remove endogenous Ig and other potential surface masking proteins, as well as decrease sample viscosity, resulted in restoration of FcMBL binding (mean: 76% +/- 5.7). ***: p-value < 0.0001.…”

DataSheet1_A phase 1 study of dimdazenil to evaluate the pharmacokinetics, food effect and safety in Chinese healthy subjects.pdf by Fei Wang (19534)

“…</p><p>Methods: In this phase 1 trial, 36 healthy subjects aged ≥18 years were assigned to receive a single dose of 1.5, 2.5, or 5 mg dimdazenil, with each dose cohort consisting of 12 subjects, and 14 subjects were assigned to receive a multiple 2.5 mg daily dose of dimdazenil for 5 days. …”

Novel design and performance analysis of a selectively filtered nanofluid spectrum semi-trough solar concentrated photovoltaic/thermal system by Gang Wang (36685)

“…The selected nanofluid for the SPVT system has an average absorptance of 53.5% and an average transmittance of 46.5% in 250.0 ~ 2500.0 nm. …”

Myosin and lipid raft formation are required for the shift of ICAM-1 to the immobile fraction. by Jaap D. van Buul (5650009)

“…Experiment is done three times. Data are mean ± SEM. *p<0.05. (<b>C</b>) Cells were pretreated with 5mM methyl-β-cyclodextrin for 30 minutes (β-CD). …”

Supplementary Material for: Idiopathic Membranous Nephropathy: Clinical and Histologic Prognostic Features and Treatment Patterns over Time at a Tertiary Referral Center by Sprangers B. (4133701)

Quantification of specific fecal bacteria species 3 to 9 months after kidney transplantation. by Marie Lecronier (5037926)

Targeting hTERT Promoter G‑Quadruplex DNA Structures with Small-Molecule Ligand to Downregulate hTERT Expression for Triple-Negative Breast Cancer Therapy by Wei Long (411482)

“…In cell-based assays, <b>5</b> not only exerts markedly inhibitory activity on classical telomere functions including decreased telomerase activity, shortened telomere length, and cellular senescence but also induces DNA damage, acute cellular senescence, and apoptosis. …”

Table_1_Efficacy and Safety of Tacrolimus Therapy for a Single Chinese Cohort With Very-Late-Onset Myasthenia Gravis.DOCX by Yiming Zheng (3921866)

“…For the 9 patients, newly diagnosed at enrollment within this group, MG activities of daily living (MG-ADL) decreased significantly from 3 (2-5) to 2 (1-2) (p = 0.041). …”

Datasheet4_Assessing disparities through missing race and ethnicity data: results from a juvenile arthritis registry.pdf by Katelyn M. Banschbach (19204348)

“…The project goal was to improve race and ethnicity data completion within the Pediatric Rheumatology Care Outcomes Improvement Network and assess impact of improved data completion on conclusions drawn from the registry.</p>Methods<p>This is a mixed-methods quality improvement study that consisted of five parts, as follows: (1) Identifying baseline missing race and ethnicity data, (2) Surveying current collection and entry, (3) Completing data through audit and feedback cycles, (4) Assessing the impact on outcome measures, and (5) Conducting participant interviews and thematic analysis.…”

Table 1_Temporal trends and geographic disparities in thyroid cancer burden: a global analysis from 1990 to 2021.doc by Zuzhi Zhao (21724217)

“…</p>Results<p>In 2021, the global thyroid cancer burden was substantial, with 1,987,148.5 cases. From 1990 to 2021, the ASPR increased from 14.9 (95% Uncertainty Interval [UI]: 14.1–16.0) to 23.1 (95% UI: 20.7–25.6) per 100,000 population, with an EAPC of 1.58 (95% UI: 1.44–1.73); the ASIR increased from 2.1 (95% UI: 2–2.2) to 2.9 (95% UI: 2.6–3.2) per 100,000 population, with an EAPC of 1.25 (95% UI: 1.14–1.37); the ASDR declined from 0.6 (95% UI: 0.5–0.6) to 0.5 (95% UI: 0.5–0.6) per 100,000 population, with an EAPC of −0.24 (95% UI: −0.24 – −0.21); the age - standardized DALY rate decreased from 15.2 (95% UI: 14.2–16.8) to 14.6 (95% UI: 12.8–16.1) per 100,000 population, with an EAPC of −0.14 (95% UI: −0.17 – –0.11). …”

Datasheet2_Assessing disparities through missing race and ethnicity data: results from a juvenile arthritis registry.pdf by Katelyn M. Banschbach (19204348)

“…The project goal was to improve race and ethnicity data completion within the Pediatric Rheumatology Care Outcomes Improvement Network and assess impact of improved data completion on conclusions drawn from the registry.</p>Methods<p>This is a mixed-methods quality improvement study that consisted of five parts, as follows: (1) Identifying baseline missing race and ethnicity data, (2) Surveying current collection and entry, (3) Completing data through audit and feedback cycles, (4) Assessing the impact on outcome measures, and (5) Conducting participant interviews and thematic analysis.…”